Livzon Pharmaceutical Group Inc
SZSE:000513
Intrinsic Value
Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. [ Read More ]
The intrinsic value of one
Livzon Pharmaceutical Group Inc
stock under the Base Case scenario is
44.25
CNY.
Compared to the current market price of 37.52 CNY,
Livzon Pharmaceutical Group Inc
is
Undervalued by 15%.
Livzon Pharmaceutical Group Inc's market capitalization is 34.7B CNY.
Livzon Pharmaceutical Group Inc stock price is 37.52 CNY.
Livzon Pharmaceutical Group Inc stock price (37.52 CNY) is 15% less than its Intrinsic Value (44.25 CNY).
Livzon Pharmaceutical Group Inc stock price (37.52 CNY) is 15% less than its DCF Value (44.25 CNY). Open DCF Valuation
Livzon Pharmaceutical Group Inc stock price (37.52 CNY) is 15% less than its Relative Value (44.25 CNY). Open Relative Valuation
Livzon Pharmaceutical Group Inc has upside potential of 9% compared to the average analyst price target.
Open Wall St Estimates
Livzon Pharmaceutical Group Inc's Revenue has dropped by 2% over the past 12 months.
Livzon Pharmaceutical Group Inc's ROE (Return on Equity) has decreased in the last 3 years from 15% to 14%.
Livzon Pharmaceutical Group Inc's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 13%.
Livzon Pharmaceutical Group Inc's ROE (Return on Equity) for the past 12 months is positive and is equal to 14%.
Livzon Pharmaceutical Group Inc's Revenue has been growing by 6% per year for the last 3 years.
Livzon Pharmaceutical Group Inc's Revenue is forecast to grow at a rate of 7% per year over the next 3 years.
Livzon Pharmaceutical Group Inc has positive Net Income for the last twelve months.
Livzon Pharmaceutical Group Inc has positive three-year average ROE (Return on Equity): 14%. The company is efficient at transforming stockholders' equity into net income.
Livzon Pharmaceutical Group Inc has positive Operating Income for the last twelve months.
Livzon Pharmaceutical Group Inc's ROIC (Return on Invested Capital) has decreased in the last 3 years from 21% to 13%.
Livzon Pharmaceutical Group Inc has positive three-year average ROIC (Return on Invested Capital): 16%. The company is efficient at using invested capital to generate operating income.
Livzon Pharmaceutical Group Inc has positive Free Cash Flow for the last twelve months.
Livzon Pharmaceutical Group Inc's short-term assets (17B CNY) exceed its short-term liabilties (8B CNY).
Livzon Pharmaceutical Group Inc's Altman Z-Score is very high and is equal to 3.22.
Livzon Pharmaceutical Group Inc's long-term assets (25B CNY) exceed its long-term liabilties (11B CNY).
Livzon Pharmaceutical Group Inc has positive Gross Profit for the last twelve months.
Livzon Pharmaceutical Group Inc has negative Net Debt. This means that the company has more cash and short-term investments (11B CNY) than debt (4B CNY).
Livzon Pharmaceutical Group Inc's D/E (Debt to Equity) is very low and is equal to 0.31.
Valuation Backtest
Livzon Pharmaceutical Group Inc
Run backtest to discover the historical profit from buying and selling
Livzon Pharmaceutical Group Inc
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Livzon Pharmaceutical Group Inc
Balance Sheet Decomposition
Livzon Pharmaceutical Group Inc
| Current Assets | 17.3B |
| Cash & Short-Term Investments | 11.4B |
| Receivables | 3.7B |
| Other Current Assets | 2.2B |
| Non-Current Assets | 7.8B |
| Long-Term Investments | 1.7B |
| PP&E | 4.7B |
| Intangibles | 839.1m |
| Other Non-Current Assets | 524.8m |
| Current Liabilities | 8.1B |
| Accounts Payable | 763.8m |
| Accrued Liabilities | 388.2m |
| Short-Term Debt | 2.8B |
| Other Current Liabilities | 4.2B |
| Non-Current Liabilities | 2.9B |
| Long-Term Debt | 1.6B |
| Other Non-Current Liabilities | 1.3B |
Earnings Waterfall
Livzon Pharmaceutical Group Inc
|
Revenue
|
12.4B
CNY
|
|
Cost of Revenue
|
-4.8B
CNY
|
|
Gross Profit
|
7.7B
CNY
|
|
Operating Expenses
|
-5.6B
CNY
|
|
Operating Income
|
2.1B
CNY
|
|
Other Expenses
|
-149.7m
CNY
|
|
Net Income
|
2B
CNY
|
Free Cash Flow Analysis
Livzon Pharmaceutical Group Inc
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Livzon Pharmaceutical Group Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Livzon Pharmaceutical Group Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Livzon Pharmaceutical Group Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Livzon Pharmaceutical Group Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Livzon Pharmaceutical Group Inc
According to Wall Street analysts, the average 1-year price target for
Livzon Pharmaceutical Group Inc
is 40.71 CNY
with a low forecast of 32.32 CNY and a high forecast of 49.88 CNY.
Shareholder Return
Price
Livzon Pharmaceutical Group Inc
| Average Annual Return | 12.19% |
| Standard Deviation of Annual Returns | 25.47% |
| Max Drawdown | -47% |
| Market Capitalization | 34.7B CNY |
| Shares Outstanding | 923 938 139 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Livzon Pharmaceutical Group Inc
Country
Industry
Market Cap
Dividend Yield
Description
Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong and currently employs 8,580 full-time employees. LIVZON PHARMACEUTICAL GROUP INC. is a China based company principally engaged in the research and development, production and sales of pharmaceutical products. The firm's main products include western medicine preparation such as gastrointestinal drugs, cardiovascular drugs and antimicrobial drugs and gonadotrophin drugs, Chinese medicine preparation, active pharmaceutical ingredient and intermediates, diagnostic reagents and equipments. The firm distributes its products in the domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one
Livzon Pharmaceutical Group Inc
stock under the Base Case scenario is
44.25
CNY.
Compared to the current market price of 37.52 CNY,
Livzon Pharmaceutical Group Inc
is
Undervalued by 15%.
You don't have any saved screeners yet
